Evidence map›Paper›PMID 37111615›Full record

ArticlePharmaceutics2023

Fabricating a PDA-Liposome Dual-Film Coated Hollow Mesoporous Silica Nanoplatform for Chemo-Photothermal Synergistic Antitumor Therapy.

Chuanyong Fan, Xiyu Wang, Yuwen Wang, Ziyue Xi, Yuxin Wang, Shuang Zhu, Miao Wang, Lu Xu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Chuanyong FanSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Xiyu WangSchool of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
Yuwen WangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Ziyue XiSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Yuxin WangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Shuang ZhuSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Miao WangSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
Lu XuSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.ORCID 0000-0002-8739-692X
Shenyang Pharmaceutical University · CN

Funding

Research Project of Department of Education of Liaoning Province China, No. LJKMZ20221363
6 · The paper itself

Abstract

In this study, we synthesized hollow mesoporous silica nanoparticles (HMSNs) coated with polydopamine (PDA) and a D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS)-modified hybrid lipid membrane (denoted as HMSNs-PDA@liposome-TPGS) to load doxorubicin (DOX), which achieved the integration of chemotherapy and photothermal therapy (PTT). Dynamic light scattering (DLS), transmission electron microscopy (TEM), N

Indexed as

chemo-photothermal therapydoxorubicinhollow mesoporous silicaliposome-TPGSpolydopamine

Identifiers

PMID37111615
PMCPMC10144002
OpenAlexW4362561388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.